Form 4: PTC Therapeutics Executive Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Lee Scott Golden, EVP & Chief Medical Officer of PTC Therapeutics, sold shares of common stock to cover tax withholding obligations related to RSU vesting.
Summary
- Lee Scott Golden, an executive at PTC Therapeutics, sold shares of the company's common stock on February 19 and 20, 2025.
- The sales were executed to cover tax withholding obligations associated with the vesting of Restricted Stock Units (RSUs).
- On February 19, 2025, 795 shares were sold at a price of $50.096 per share.
- On February 20, 2025, 962 shares were sold at a price of $50.124 per share.
- Following these transactions, Golden directly owns 76,894 shares of PTC Therapeutics common stock.
Sentiment
Score: 5
Explanation: This is a routine transaction related to tax obligations, so it's neutral in sentiment.
Industry Context
Executive stock sales for tax purposes are a common occurrence, particularly around RSU vesting events. This is a normal part of executive compensation and financial planning.
Stakeholder Impact
- The stock sales may have a minor dilutive effect on shareholders.
Key Dates
| Date | Description |
|---|---|
| 02/15/2024 | Date of RSU grant of 20,000 RSUs. |
| 02/15/2024 | Date of RSU grant of 2,600 RSUs. |
| 02/19/2025 | Date of first stock sale. |
| 02/20/2025 | Date of second stock sale. |
| 02/21/2025 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.